Latest intelligence


Pearce IP BioBlast w/e 03 May 2024

Pearce IP

On 3 May 2024, Indian-headquartered Lupin, in partnership with Sandoz, announced its Canadian launch of etanercept biosimilar Rymti®, biosimilar to…...

Maximizing California Court Success Through Rule Mastery

Harris Sliwoski LLP

The Court Rules are Everything For we lawyers, adherence to rules is paramount. Attorneys thrive on structure, order, and, you guessed it, rules. But…...

With the DEA reportedly ready to ease restrictions on marijuana, the ADA landscape changes for employers

Pierson Ferdinand LLP

Last week, the Associated Press reported that the U.S. Drug Enforcement Administration would move to reclassify marijuana (cannabis), moving it from…...

When It Rains, It Pours: Supreme Court, EEOC and DOL Release Flood of Employment Law Developments

Dechert LLP

The last several weeks have seen a flurry of significant developments in federal employment law. The Supreme Court decided a significant case…...

Challenges and opportunities: A global review of regulatory developments surrounding AI and machine learning as devices in healthcare settings

Ropes & Gray LLP

My colleague, Greg Levine, who Chairs our FDA regulatory compliance practice, and I had a very informative conversation in a webinar on 30 April 2024…...


Show More